Nestle near deal for Pfizer's baby formula unit - WSJ

Wed Apr 18, 2012 6:39am IST

Related Topics

Stocks

   
A statue of Ganesh, the deity of prosperity, is carried in a taxi to a place of worship on the first day of the ten-day-long Ganesh Chaturthi festival in Mumbai August 29, 2014. REUTERS/Danish Siddiqui

Ganesh Chaturthi Festival

During Ganesh Chaturthi idols will be taken through the streets in a procession accompanied by dancing and singing, and will be immersed in a river or the sea in accordance with Hindu faith.  Slideshow 

REUTERS - Pfizer Inc (PFE.N) is near a deal to sell its baby formula business to Swiss food giant Nestle SA (NESN.VX) for at least $9 billion, the Wall Street Journal reported on Tuesday.

Citing people familiar with the matter, the Journal said Nestle appears to have outstripped Danone and Mead Johnson Nutrition Co, who had teamed up for a bid, and that a deal could be announced as soon as next week.

Nestle, the world's biggest packaged food company, was already seen as a favored bidder due largely to its deep pockets.

Bloomberg reported that Danone and Nestle both submitted final offers of about $10 billion for the business, citing people with knowledge of the matter.

According to that report, Danone has told outsiders that it is unlikley to win the unit, but that Pfizer is trying to keep them in the auction, one of the people said. Bloomberg said a third bidder is no longer in the running.

Separately, Pfizer has hired JPMorgan Chase & Co, Bank of America Merrill Lynch and Morgan Stanley for a potential initial public offering of its animal health business, a source familiar with the situation said.

Pfizer put its infant nutrition and animal health businesses up for sale last July as it looks to focus on its core pharmaceuticals business.

A company official said on Tuesday that no decisions have been made and that Pfizer will be in a position to announce any decisions this year. The company expects to complete any transactions between July of this year and July 2013.

Regarding the animal health business, the official said a spin-off was most likely.

A Nestle spokesman was not immediately available for comment.

A person familiar with the negotiations said a deal for the infant nutrition unit was expected "in the near future," but not this week.

Pfizer's infant nutrition business sells baby formula and maternal supplements. It generates over 70 percent of its $2.1 billion in sales in emerging markets, with over a quarter coming from China, where the $6 billion market is expected to double by 2016.

The Pfizer business competes with products from Nestle and Danone, as well as Mead Johnson's Enfamil and Abbott Laboratories' Similac.

Pfizer shares closed 1.5 percent higher on Tuesday.

(Reporting by Olivia Oran, Ransdell Pierson, Martinne Geller and Michael Erman in New York; Editing by Gunna Dickson, Bernard Orr, Tim Dobbyn and Sugita Katyal)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Coal Block Allocation

Coal Block Allocation

Government urges Supreme Court to not cancel some 'illegal' coal mines  Full Article 

Modi in Japan

Modi in Japan

Japan and India agree to boost strategic ties at summit  Full Article 

HSBC PMI

HSBC PMI

Factory activity expands at slower clip in August.  Full Article 

Current Account

Current Account

Balance of payments surplus for third straight quarter  Full Article 

India Infrastructure

India Infrastructure

RBI rule handicaps India's infrastructure hopes  Full Article 

Book Talk

Book Talk

Reema Abbasi and a glimpse of Pakistan’s Hindu past  Full Article 

China Economy

China Economy

Retreat in China's PMIs heightens calls for policy easing.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage